http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019204031-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5767e6f4534b8102fec450e1ee9a0c83 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-34 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3604 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3683 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 |
| filingDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e523fc6317d4f2f8474baf2801fd26f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea31c5be9979ab35db8750f4219a596b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0344f3f0bb3b2f0bee5c73f52e46e29b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5efae4ab6062bcb15a6beea299d3a359 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8dfacb2718165b537f6f0ca01ae7d25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d37d4db8438e17726a9451f33a3e12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd05e575ab7676c3d0ea24a8b40ef162 |
| publicationDate | 2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2019204031-A1 |
| titleOfInvention | Acellular soft tissue-derived matrices and methods for preparing same |
| abstract | Compositions including a first soft tissue-derived matrix and a second soft tissuenderived matrix are provided, as well as methods of making such compositions. In some nembodiments, the composition comprises delipidated, decellularized adipose tissuen5 derived matrix and delipidated, decellularized fascial tissue-derived matrix, which may be ncombined in various proportions. Such adipose-fascia matrix compositions provide nimproved volume retention when implanted into a patient. The composition may further ninclude exogenous cells or other substances, and/or a carrier. The composition is suitable nfor use inplastic surgery procedures, including reconstructive or cosmetic surgery n.0 procedures, as well as procedures for wound treatment and tissue regeneration. The nmethods for making the compositions may involve separation of first and second soft ntissues from one another, followed by performing one or more treatments on the nseparated soft tissues, then combining the treated soft tissues and, optionally, performing none or more additional treatments on the combined soft tissues. n.5 n211nIsolating a sample nof soft tissue nPre-processing nthe soft tissue nDelipidizing nthe soft tissue nDecellularizing nthe soft tissue nDisinfecting nthe soft tissue nPost-processing nthe soft tissue nPackaging nthe soft tissue nFIG. 1 |
| priorityDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1850.